| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 338 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 315 |
| 2 | TACROLIMUS OINTMENT 0.1% | 315 |
| 3 | MYCOPHENOLATE MOFETIL | 305 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 305 |
| 5 | PREDNISONE | 256 |
| 6 | PREDNISOLONE | 224 |
| 7 | PREDNISOLONE ORAL | 224 |
| 8 | PREDNISOLONE ORAL SOLUTION | 224 |
| 9 | CYCLOPHOSPHAMIDE | 201 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 8 | 0.0165 |
| 1 | TREOSULFAN | 38 | 0.0138 |
| 2 | DAUNORUBICIN HYDROCHLORIDE | 20 | 0.0121 |
| 3 | BULEVIRTIDE | 1 | 0.0104 |
| 4 | THIOTEPA | 92 | 0.0094 |
| 5 | EMAPALUMAB-LZSG | 2 | 0.0084 |
| 6 | CIDOFOVIR ANHYDROUS | 12 | 0.0083 |
| 7 | FOSTEMSAVIR TROMETHAMINE | 2 | 0.0082 |
| 8 | EVEROLIMUS TABLETS | 125 | 0.0073 |
| 9 | BRINCIDOFOVIR | 1 | 0.0072 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon gamma Blocker [EPC] | 2 | 0.0084 |
| 1 | Asparagine-specific Enzyme [EPC] | 79 | 0.0059 |
| 2 | CD4-directed Blocking Antibody [EPC] | 3 | 0.0056 |
| 3 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 13 | 0.0053 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 93 | 0.0048 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 63 | 0.0028 |
| 6 | Selective T Cell Costimulation Blocker [EPC] | 12 | 0.0025 |
| 7 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 119 | 0.0024 |
| 8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 46 | 0.0019 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 205 | 0.0019 |